Quality of reporting of randomized controlled trials of herbal medicines conducted in metabolic disorders in Middle East countries: A systematic review

Complementary Therapies in Medicine - Tập 38 - Trang 61-66 - 2018
Ozra Tabatabaei-Malazy1,2, Zhaleh Shadman1,2, Hanieh-Sadat Ejtahed3, Rasha Atlasi4,5, Mohammad Abdollahi2,6,7, Bagher Larijani2
1Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular, Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
4Evidence Based Practice Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
5Department of Medical Library & Information Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
6Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
7Department of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

Tài liệu tham khảo

Mishra, 2011, Natural products: an evolving role in future drug discovery, Eur J Med Chem, 46, 4769, 10.1016/j.ejmech.2011.07.057 Kelly, 2005, Recent trends in use of herbal and other natural products, Arc Intern Med, 165, 281, 10.1001/archinte.165.3.281 Hasani-Ranjbar, 2009, A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity, World J Gastroenterol, 15, 3073, 10.3748/wjg.15.3073 Hasani-Ranjbar, 2013, A systematic review of antiobesity medicinal plants- an update, J Diabetes Metab Disord, 12, 28, 10.1186/2251-6581-12-28 Hasani-Ranjbar, 2010, The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review, Cur Pharm Des, 16, 2935, 10.2174/138161210793176464 Salari, 2008, A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis, Med Sci Monit, 14, RA37 Tabatabaei-Malazy, 2015, Targeting metabolic disorders by natural products, J Diabetes Metab Disord, 14, 57, 10.1186/s40200-015-0184-8 Tabatabaei-Malazy, 2016, Trends in publication on evidence-based antioxidative herbal medicines in management of diabetic nephropathy, J Diabetes Metab Disord, 15, 1, 10.1186/s40200-016-0221-2 Hasani-Ranjbar, 2013, Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders, J Diabetes Metab Disord, 12, 49, 10.1186/2251-6581-12-49 Hasani-Ranjbar, 2014, Medicinal plants as potential new target drugs in endocrine disorders-review article, Iran J Public Health, 43, 24 Hasani-Ranjbar, 2009, A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases, Inflamm Allergy Drug Targets, 8, 2, 10.2174/187152809787582561 Tabatabaei-Malazy, 2013, A novel management of diabetes by means of strong antioxidants’ combination, J Med Hypotheses Ideas, 7, 25, 10.1016/j.jmhi.2012.12.002 Hosseini, 2012, It is time to formulate an antioxidant mixture for management of diabetes and its complications: notice for pharmaceutical industries, Int J Pharmacol, 8, 60, 10.3923/ijp.2012.60.61 Rahimi, 2010, A review of the herbal phosphodiesterase inhibitors: future perspective of new drugs, Cytokine, 49, 123, 10.1016/j.cyto.2009.11.005 Newman, 2012, Natural products as sources of new drugs over the 30 years from 1981 to 2010, J Nat Prod, 75, 311, 10.1021/np200906s Chalmers, 1981, A method for assessing the quality of a randomized control trial, Control Clin Trials, 2, 31, 10.1016/0197-2456(81)90056-8 Odgaard-Jensen, 2011, Randomization to protect against selection bias in healthcatre trials, Cochrane Database Syst Rev, 4 Howick J, Chalmers I, Glasziou P, et al. Oxford Centre for Evidence-Based Medicine; Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence (Background Document) Available in: www.cebm.net/index.aspx?o=5653, Accessed 2014. Wood, 2008, Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study, BMJ, 336, 601, 10.1136/bmj.39465.451748.AD Plint, 2006, Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review, Med J Aust, 185, 263, 10.5694/j.1326-5377.2006.tb00557.x Cui, 2014, Does the CONSORT checklist for abstracts improve the quality of reports of randomized controlled trials on clinical pathways?, J Eval Clin Pract, 20, 827, 10.1111/jep.12200 Turner, 2012, Consolidation standards of reporting trials (CONSORT) and the completeness of reporting of randomized controlled trials (RCTs) published in medical journals, Cochrane Database Syst Rev, 11 Zhai, 2015, Methodological Reporting Quality of Randomized Controlled Trials in 3 Leading Diabetes Journals From 2011–2013 Following CONSORT Statement: A System Review, Medicine (Baltimore), 94, e1083, 10.1097/MD.0000000000001083 Nojomi, 2013, Quality of reports on randomized controlled trials published in Iranian journals: application of the new version of consolidated standards of reporting trials (CONSORT), Arch Iran Med, 16, 20 He, 2011, Quality assessment of reporting of randomization, allocation concealment, and blinding in traditional Chinese medicine RCTs: a review of 3159 RCTs identified from 260 systematic reviews, Trials, 12, 122, 10.1186/1745-6215-12-122 Choi, 2014, Endorsement of improving the quality of reports on randomized controlled trials of traditional medicine journals in Korea: a systematic review, Trials, 15, 429, 10.1186/1745-6215-15-429 List of Middle East Countries by Population. Available in: http://www.en.wikipedia.org/wiki/List_of_Middle_East_countries_by_population, Accessed 23 Agu 2017. Simera, 2010, A catalogue of reporting guidelines for health research, Eur J Clin Invest, 40, 35, 10.1111/j.1365-2362.2009.02234.x GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, 2016, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet, 388, 1545, 10.1016/S0140-6736(16)31678-6 Larijani, 2009, Iran’s health innovation and science development planby 2025, Iran J Public Health, 38, 13 Djalalinia, 2015, Obesity researches over the past 24 years: a scientometrics study in Middle East countries, Int J Prev Med, 6, 38, 10.4103/2008-7802.156835 Massarrat, 2011, Critical assessment of progress of medical sciences in Iran and Turkey: the way developing countries with limited resources should make effective contributions to the production of science, Arch Iran Med, 14, 370 Biglu, 2014, Authorship, institutional and citation metrics for publications on postmenopausal osteoporosis, Osteoporos Int, 25, 1337, 10.1007/s00198-013-2603-3 Brüggmann, 2016, World-wide architecture of osteoporosis research: density-equalizing mapping studies and gender analysis, Climacteric, 19, 463, 10.1080/13697137.2016.1200548 Kumar, 2012, Trends in endocrinology related research articles in a medical journal from India, Indian J Endocrinol Metab, 16, 931, 10.4103/2230-8210.102993 Gagnier, 2006, Quality of reporting of randomized controlled trials of herbal medicine interventions, Am J Med, 119, 10.1016/j.amjmed.2006.02.006 NCD Risk Factor Collaboration (NCD-RisC), 2016, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants, Lancet, 387, 1513, 10.1016/S0140-6736(16)00618-8 Peykari, 2015, Diabetes research in Middle East countries; a scientometrics study from 1990 to 2012, J Res Med Sci, 20, 253, 10.4103/1735-1995.156173 Nasli-Esfahani, 2017, Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran, J Diabetes Metab Disord, 16, 9, 10.1186/s40200-017-0291-9 Ramin, 2015, Scientometric analysis and mapping of scientific articles on diabetic retinopathy, Med Hypothesis Discov Innov Ophthalmol, 4, 81 Mirfeizi, 2016, Controlling type 2 diabetes mellitus with herbal medicines: a triple-blind randomized clinical trial of efficacy and safety, J Diabetes, 8, 647, 10.1111/1753-0407.12342 Heshmati, 2015, Nigella sativa oil affects glucose metabolism and lipid concentrations in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial, Food Res Int, 70, 87, 10.1016/j.foodres.2015.01.030 Tabatabaei-Malazy, 2016, Scientometric study of academic publications on antioxidative herbal medicines in type 2 diabetes mellitus, J Diabetes Metab Disord, 15, 48, 10.1186/s40200-016-0273-3 Farzanegi, 2013, Effect of portulaca oleracea seeds on the levels of matrix metalloproteinase 2, 9 and tissue inhibitor matrix metalloproteinase 1 in patients with type 2 diabetes, Modares J Med Sci, 16, 65 Page, 2016, Empirical evidence of study design biases in randomized trials: systematic review of meta-Epidemiological studies, PLoS One, 11, e0159267, 10.1371/journal.pone.0159267 Wang, 2007, The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China, Clin Ther, 29, 1456, 10.1016/j.clinthera.2007.07.023 Ahmed Ali, 2013, Trends in worldwide volume and methodological quality of surgical randomized controlled trials, Ann Surg, 258, 199, 10.1097/SLA.0b013e31829c7795 Turner, 2012, Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review, Syst Rev, 1, 60, 10.1186/2046-4053-1-60 Cheng, 2017, CONSORT Extension for Chinese Herbal Medicine Formulas 2017: recommendations, explanation, and elaboration (Traditional Chinese Version), Ann Intern Med, 167, w7, 10.7326/IsTranslatedFrom_M17-2977_1